Suyash Prasad's Net Worth
$5.21 Million
Who is Suyash Prasad?
Suyash Prasad has an estimated net worth of $5.21 Million. This is based on reported shares across multiple companies, which include Taysha Gene Therapies, Inc., and Audentes Therapeutics, Inc..
SEC CIK
Suyash Prasad's CIK is 0001679129
Past Insider Trading and Trends
2018 was Suyash Prasad's most active year for acquiring shares with 11 total transactions. Suyash Prasad's most active month to acquire stocks was the month of September. 2018 was Suyash Prasad's most active year for disposing of shares, totalling 14 transactions. Suyash Prasad's most active month to dispose stocks was the month of May. 2018 saw Suyash Prasad paying a total of $38,151.36 for 30,736 shares, this is the most they've acquired in one year. In 2021 Suyash Prasad cashed out on 79,000 shares for a total of $1,787,935.64, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Taysha Gene Therapies, Inc. (TSHA) Snapshot price: $2.09
CMO and Head R&DSuyash Prasad owns 530,589 units of Common Stock which is worth $1,108,931.01. In the year 2020 Suyash Prasad filed a total of 9 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -2.37% | -12.86K |
$3.70 | -$47,649.79 | 530.59K |
Scheduled
|
Jul 5 - Jul 6
| ||
Form 4
| -8.45% | -50.14K |
$3.65 | -$183,080.87 | 543.45K |
Scheduled
|
Jun 29 - Jul 1
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 23
| |||
Form 4
| -11.75% | -79.00K |
$22.63 | -$1,787,935.64 | 593.59K |
Scheduled
|
Jun 29 - Jul 1
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 19
| |||
Form 4
| +0.57% | 3.84K |
—
|
—
| 672.59K |
Sep 28
| |||
Form 4
|
∞
| 668.75K |
—
|
—
| 668.75K |
Sep 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Audentes Therapeutics, Inc. No price found
Senior VP & Chief Med OfficerSuyash Prasad owns 17,479 units of Common Stock. Suyash Prasad used to own units in Copmmon Stock but no longer holds any shares there.acquired a total of 84,236 shares in Audentes Therapeutics, Inc. at a cost of $66,591.36, Suyash also disposed a total of 66,757 shares of Audentes Therapeutics, Inc. equalling to $2,151,390.26.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -4.15% | -757.00 |
$37.31 | -$28,243.67 | 17.48K |
Jun 5
| |||
Form 4
|
—
|
0
|
$18.88 | -$361,898.19 | 18.24K |
Scheduled
|
May 13
| ||
Form 4
|
—
|
0
|
$15.43 | -$292,653.00 | 18.24K |
Scheduled
|
Feb 25
| ||
Form 4
| +2,377.72% | 17.5K |
—
|
—
| 18.24K |
Feb 6
| |||
Form 4
|
∞
| 736 |
$19.64 | $14,451.36 | 736 |
Nov 15
| |||
Form 4
|
—
|
0
|
$18.84 | -$360,888.37 |
0
|
Scheduled
|
Oct 1
| ||
Form 4
|
—
|
0
|
$19.60 | -$376,167.39 | 5.01K |
Scheduled
|
Jul 2
| ||
Form 4
|
—
|
0
|
$15.41 | -$228,033.00 |
0
|
Scheduled
|
Mar 29 - Mar 29
| ||
Form 4
|
—
|
0
|
$15.40 | -$64,262.00 |
0
|
Scheduled
|
Mar 27 - Mar 27
| ||
Form 4
|
—
|
0
|
$14.66 | -$221,943.84 |
0
|
Scheduled
|
Dec 1
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 16
| |||
Form 4
|
—
|
0
|
$11.12 | -$165,160.80 |
0
|
Scheduled
|
Sep 1
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||